Skip to Content
Merck
  • Multiple system organ response induced by hyperoxia in a clinically relevant animal model of sepsis.

Multiple system organ response induced by hyperoxia in a clinically relevant animal model of sepsis.

Shock (Augusta, Ga.) (2014-07-01)
Raquel Rodríguez-González, José Luis Martín-Barrasa, Ángela Ramos-Nuez, Ana María Cañas-Pedrosa, María Teresa Martínez-Saavedra, Miguel Ángel García-Bello, Josefina López-Aguilar, Aurora Baluja, Julián Álvarez, Arthur S Slutsky, Jesús Villar
ABSTRACT

Oxygen therapy is currently used as a supportive treatment in septic patients to improve tissue oxygenation. However, oxygen can exert deleterious effects on the inflammatory response triggered by infection. We postulated that the use of high oxygen concentrations may be partially responsible for the worsening of sepsis-induced multiple system organ dysfunction in an experimental clinically relevant model of sepsis. We used Sprague-Dawley rats. Sepsis was induced by cecal ligation and puncture. Sham-septic controls (n = 16) and septic animals (n = 32) were randomly assigned to four groups and placed in a sealed Plexiglas cage continuously flushed for 24 h with medical air (group 1), 40% oxygen (group 2), 60% oxygen (group 3), or 100% oxygen (group 4). We examined the effects of these oxygen concentrations on the spread of infection in blood, urine, peritoneal fluid, bronchoalveolar lavage, and meninges; serum levels of inflammatory biomarkers and reactive oxygen species production; and hematological parameters in all experimental groups. In cecal ligation and puncture animals, the use of higher oxygen concentrations was associated with a greater number of infected biological samples (P < 0.0001), higher serum levels of interleukin-6 (P < 0.0001), interleukin-10 (P = 0.033), and tumor necrosis factor-α (P = 0.034), a marked decrease in platelet counts (P < 0.001), and a marked elevation of reactive oxygen species serum levels (P = 0.0006) after 24 h of oxygen exposure. Oxygen therapy greatly influences the progression and clinical manifestation of multiple system organ dysfunction in experimental sepsis. If these results are extrapolated to humans, they suggest that oxygen therapy should be carefully managed in septic patients to minimize its deleterious effects.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Aluminum oxide, nanopowder, 13 nm primary particle size (TEM), 99.8% trace metals basis
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, nanopowder, <50 nm particle size (TEM)
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, nanoparticles, <50 nm particle size (DLS), 20 wt. % in isopropanol
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, purified grade, ≥98.5%, powder
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, BioUltra, anhydrous, ≥99% (titration)
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, ACS reagent, 99.4-100.6%, powder
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid solution, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, 99.995% trace metals basis
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid disodium salt solution, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
Pricing and availability is not currently available.
Supelco
Aluminum oxide, for the determination of hydrocarbons
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, BioUltra, ≥99.0% (KT)
Pricing and availability is not currently available.
Sigma-Aldrich
Ethylenediaminetetraacetic acid, ≥98.0% (KT)
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, 99.997% trace metals basis
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, nanowires, diam. × L 2-6 nm × 200-400 nm
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, nanoparticles, 30-60 nm particle size (TEM), 20 wt. % in H2O
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Aluminum oxide, single crystal substrate, <0001>
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Aluminum oxide, powder, 99.99% trace metals basis
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, pore size 58 Å, ~150 mesh
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, Type WN-6, Neutral, Activity Grade Super I
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, Corundum, α-phase, -100 mesh
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, fused, powder, primarily α-phase, -325 mesh
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, fused, powder, primarily α-phase, 100-200 mesh
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, activated, basic, Brockmann I
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, activated, neutral, Brockmann I
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, activated, acidic, Brockmann I
Pricing and availability is not currently available.
Sigma-Aldrich
Aluminum oxide, mesoporous, MSU-X (wormhole), average pore size 3.8 nm
Pricing and availability is not currently available.
Supelco
Aluminum oxide, activated, neutral, Brockmann Activity I
Pricing and availability is not currently available.